The importance of microRNAs in the stroma-breast cancer cell interplay

Cancer Biomarkers

Volumn 14, Issue 2-3, 2014, Pages 137-144

  Susman, Sergiu ^a,b   Tomuleasa, Ciprian ^b,c,d   Fekete, Zsolt ^d   Pilato, Brunella ^e   Irimie, Alexandru ^b,d   Berindan Neagoe, Ioana ^b,d  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Research Center for Functional Genomics and Translational Medicine   (Romania)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d THE ONCOLOGY INSTITUTE PROF DR ION CHIRICUTA   (Romania)

^e NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Breast cancer; microRNA; tumor microenvironement

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MICRORNA; MICRORNA 101; MICRORNA 133A; MICRORNA 145; MICRORNA 203; MICRORNA 205; MICRORNA 21; MICRORNA 224; MICRORNA 31; MICRORNA 320; MICRORNA 92A; STROMAL CELL DERIVED FACTOR 1; STROMAL CELL DERIVED FACTOR 1ALPHA; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; BILE DUCT CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER STEM CELL; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; EARLY DIAGNOSIS; ENDOTHELIUM CELL; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; FIBROBLAST; GLIOMA; HOMEOSTASIS; HUMAN; IMMUNOCOMPETENT CELL; INTRACELLULAR SIGNALING; LIVER CELL CARCINOMA; MESENCHYMAL STEM CELL; METASTASIS; PERICYTE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; STROMA CELL; SYMBIOSIS; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH; TUMOR MICROENVIRONMENT; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

BREAST NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; NEOPLASTIC STEM CELLS; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84904330168     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-130318     Document Type: Article

References (94)

1. A. Aboussekhra, Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int J Dev Biol 7-9 (2011), 841-849.
2. M. Al-Hajj, M.S. Wicha, A. Benito-Hernandez, S.J. Morrison and M.F. Clarke, Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 7 (2003), 3983-3988.
3. B. Bao, S. Ali, D. Kong, S.H. Sarkar and Z. Wang, Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer. PLoS One 3 (2011), e17850.
4. F.F. Beça, P. Caetano, R. Gerhard, C.A. Alvarenga, M. Gomes, J. Paredes and F. Schmitt, Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types. Clin Pathol (2012).
5. E. Bevilacqua, C.A. Frankenberger and M.R. Rosner, RKIP Suppresses Breast Cancer Metastasis to the Bone by Regulating Stroma-Associated Genes. Int J Breast Cancer 2012 (2012), 124704.
6. N.A. Bhowmick, E.G. Neilson and H.L. Moses, Stromal fibroblasts in cancer initiation and progression. Nature 7015 (2004), 332-337.
7. B.J. Boersma, M. Reimers, M. Yi, J.A. Ludwig, B.T. Luke, R.M. Stephens, H.G. Yfantis, D.H. Lee, J.N. Weinstein and S. Ambs, A stromal gene signature associated with inflammatory breast cancer. Int J Cancer 6 (2008), 1324-1332.
8. T. Brabletz, F. Hlubek, S. Spaderna, O. Schmalhofer, E. Hiendlmeyer, A. Jung and T. Kirchner, Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and betacatenin. Cells Tissues Organs 1-2 (2005), 56-65.
9. T.A. Brentnall, L.A. Lai, J. Coleman, M.P. Bronner, S. Pan and R. Chen, Arousal of cancer-associated stroma: overexpression of palladin activates fibroblasts to promote tumor invasion. PLoS One 1 (2012), e30219.
10. A. Bronisz, J. Godlewski, J.A. Wallace, A.S. Merchant, M.O. Nowicki, H. Mathsyaraja, R. Srinivasan R, A.J. Trimboli, C.K. Martin, F. Li, L. Yu, S.A. Fernandez, T. Pécot, T.J. Rosol, S. Cory, M. Hallett, M. Park, M.G. Piper, C.B. Marsh, L.D. Yee, R.E. Jimenez, G. Nuovo, S.E. Lawler, E.A. Chiocca, G. Leone and M.C. Ostrowsk, Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Bio 2 (2011), 159-167.
11. I. Büssing, F.J. Slack and H. Grosshans, let-7 microRNAs in development, stem cells and cancer. Trends Mol Med 9 (2008), 400-409.
12. G.A. Calin and C.M. Croce, MicroRNA signatures in human cancers. Nat Rev Cancer 11 (2006), 857-66.
13. G.A. Calin, C. Sevignani, C.D. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, S. Rattan, F. Bullrich, M. Negrini and C.M. Croce, Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 9 (2004), 2999-3004.
14. T. Casey, J. Bond, S. Tighe, T. Hunter, L. Lintault, O. Patel, J. Eneman, A. Crocker, J. White, J. Tessitore, M. Stanley, S. Harlow, D. Weaver, H. Muss and K. Plaut, Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Breast Cancer Res Treat 1 (2009), 47-62.
15. C.L. Chaffer and P.A. Weinberg, A perspective on cancer cell metastasis. Science 6024 (2011), 1559-1564.
16. P. Cirri and P. Chiarugi. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metastasis Rev 1-2 (2012), 195-208.
17. C.M. Croce and G.A. Calin. miRNAs, cancer, and stem cell division. Cel 1 (2005), 6-7.
18. E.M. de Kruijf, J.G. van Nes, C.J. van de Velde, H. Putte, V.T. Smit, G.J. Liefers, P.J. Kuppen, R.A. Tollenaar and W.E. Mesker, Tumor-stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patients. Breast Cancer Res Treat 3 (2011), 687-696.
19. D.J. Drasin, T.P. Robin and H.L. Ford, Breast cancer epithelial-to- mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res 6 (2011), 226.
20. N. Dumont and T.D. Tlsty, Reflections on miR-ing effects in metastasis. Cancer Cell 1 (2009), 3-4.
21. M. Fabbri, A. Paone, F. Calore, R. Galli, E. Gaudio, R. Santhanam, F. Lovat, P. Fadda, C. Mao, G.J. Nuovo, N. Zanesi, M. Crawford, G.H. Ozer, D. Wernicke, H. Alder, M.A. Caligiuri, P. Nana-Sinkam, D. Perrotti and C.M. Croce, MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci USA 31 (2012), E2110-6.
22. X. Fan, W. Matsui, L. Khaki, D. Stearns, J. Chun, Y.M. Li and C.G. Eberhart, Notch pathway inhibition depletes stemlike cells and blocks engraftment in embryonal brain tumors. Cancer Res 15 (2006), 7445-7452.
23. P. Farmer, H. Bonnefoi, P. Anderle, D. Cameron, P. Wirapati, V. Becette, S. André, M. Piccart, M. Campone, E. Brain, G. Macgrogan, T. Petit, J. Jassem, F. Bibeau, E. Blot, J. Bogaerts, M. Aguet, J. Bergh, R. Iggo and M. Delorenzi, A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer. Nat Med 1 (2009), 68-74.
24. L. Feller, B. Kramer and J. Lemmer, Pathobiology of cancer metastasis: a short account. Cancer Cell Int 1 (2012), 24.
25. G. Finak, N. Bertos, F. Pepin, S. Sadekova, M. Souleimanova, H. Zhao, H. Chen, G. Omeroglu, S. Meterissian, A. Omeroglu, M. Hallett and M. Park, Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 5 (2008), 518-527.
26. M. Guarino, Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell Bio 12 (2007), 2153-2160.
27. M. Han, M. Liu, Y. Wang, X. Chen, J. Xu, Y. Sun, L. Zhao, H. Qu and C. Fan Yand Wu, Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS One 6 (2012), e39520.
28. S. Hatfield and H. Ruohola-Baker, microRNA and stem cell function. Cell Tissue Res 1 (2008), 57-66.
29. A. Hendrix and A.N. Hume, Exosome signaling in mammary gland development and cancer. Int J Dev Biol 7-9 (2011), 879-887.
30. L. Hilakivi-Clarke and S. de Assis, Fetal origins of breast cancer. Trends Endocrinol Metab 9 (2006), 340-348.
31. M. Horie, A. Saito, Y. Mikami, M. Ohshima, Y. Morishita, J. Nakajima, T. Kohyama and T. Nagase, Characterization of human lung cancer-associated fibroblasts in three-dimensional in vitro co-culture model. Biochem Biophys Res Commun 1 (2012), 158-163.
32. J. Hu, H. Guo, H. Li, Y. Liu, J. Liu, L. Chen, J. Zhang and N. Zhang, MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4. PLoS One 9 (2012), e45965
33. D.R. Hurst, M.D. Edmonds and D.R. Welch, Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Res 19 (2009), 7495-8.
34. J.A. Joyce and J.W. Pollard, Microenvironmental regulation of metastasis. Nat Rev Cancer 4 (2009), 239-252.
35. J. Kim, R. Villadsen, T. Sørlie, L. Fogh, S.Z. Grønlund, A.J. Fridriksdottir, I. Kuhn, F. Rank, V.T. Wielenga, H. Solvang, P.A. Edwards, A.L. Børresen-Dale, L. Rønnov-Jessen, M.J. Bissell and O.W. Petersen, Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc Natl Acad Sci USA 16 (2012), 6124-6129.
36. X. Kong, G. Li, Y. Yuan, Y. He, X. Wu, W. Zhang, Z. Wu, T. Chen, W. Wu, P.E. Lobie and T. Zhu, MicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expression. PLoS One 8 (2012), e41523.
37. H. Javan, H. Gholami, M. Assadi, A.F. Pakdel, R. Sadeghi and M. Keshtgar, The accuracy of sentinel node biopsy in breast cancer patients with the history of previous surgical biopsy of the primary lesion: systematic review and meta-analysis of the literature. Eur J Surg Oncol 2 (2012), 95-109.
38. A. Jemal, R. Siegel and J. Xu and E. Ward, Cancer statistics, 2010. CA Cancer J Clin 5 (2010), 277-300.
39. P. Kharaziha, S. Ceder, Q. Li and T. Panaretakis, Tumor cellderived exosomes: A message in a bottle. Biochim Biophys Acta 1 (2012), 103-11.
40. M.G. Kellermann, L.M. Sobral, S.D. da Silva, K.G. Zecchin, E. Graner, M.A. Lopes, L.P. Kowalski and R.D. Coletta, Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 5 (2008), 509-517.
41. S.J. Kim, J.S. Oh, J.Y. Shin, K.D. Lee, K.W. Sung, S.J. Nam and K.H. Chun, Development of microRNA-145 for therapeutic application in breast cancer. J Control Release 3 (2011), 427-434.
42. S.Y. Kim, J. G. Rhee, X. Song, E.V. Prochownik, D.R. Spitz and Y.J. Lee, Breast Cancer Stem Cell-Like Cells Are More Sensitive to Ionizing Radiation than Non-Stem Cells: Role of ATM. PLoS One 11 (2012), e50423.
43. M.A. LaBarge, O.W. Petersen and M.J. Bissell, Of microenvironments and mammary stem cells. Stem Cell Rev 2 (2007), 137-46.
44. R.D. Leek and A.L. Harris, Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2 (2002), 177-189.
45. R. Leth-Larsen, M.G. Terp, A.G. Christensen, D. Elias, T. Kühlwein, O.N. Jensen, O.W. Petersen and H.J. Ditzel, Functional Heterogeneity within the CD44 High Human Breast Cancer Stem Cell-Like Compartment Reveals a Gene Signature Predictive of Distant Metastasis. Mol Med 1 (2012), 1109-1121.
46. S.J. Liao, Y.H. Zhou, Y. Yuan, D. Li, F.H. Wu, Q. Wang, J.H. Zhu, B. Yan, J.J. Wei, G.M. Zhang and Z.H. Feng, Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration. Breast Cancer Res Treat 3 (2012), 853-863.
47. E.Y. Lin, V. Gouon-Evans, A.V. Nguyen and J.W. Pollard, The macrophage growth factor CSF-1 in mammary gland development and tumor progression. J Mammary Gland Biol Neoplasia 2 (2002), 147-162.
48. H.J. Lin, T. Zuo, J.R. Chao, Z. Peng, L.K. Asamoto, S.S. Yamashita and T.H. Huang, Seed in soil, with an epigenetic view. Biochim Biophys Acta 9 (2009), 920-924.
49. E. Louie, S. Nik, J.S. Chen, M. Schmidt, B. Song, C. Pacson, X.F. Chen, S. Park, J. Ju and E.I. Chen, Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation. Breast Cancer Res 6 (2010), R94.
50. M.H. Leidenius, J.H. Vironen, P.S. Heikkilä and H. Joensuu, Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol 1 (2010), 254-262.
51. G.C. Leonardi, S. Candido, M. Cervello, D. Nicolosi, F. Raiti, S. Travali, D.A. Spandidos and M. Libra, The tumor microenvironment in hepatocellular carcinoma (review). Int J Oncol 6 (2012), 1733-1747.
52. H.J. Lin, T. Zuo, C.H. Lin, C.T. Kuo, S. Liyanarachchi, S. Sun, R. Shen, D.E. Deatherage, D. Potter, L. Asamoto, S. Lin, P.S. Yan, A.L. Cheng, M.C. Ostrowsk and T.H. Huang, Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells. Cancer Res 24 (2008), 10257-10266.
53. S. Liu, S.G. Clouthier and M.S. Wicha, Role of microRNAs in the regulation of breast cancer stem cells. J Mammary Gland Biol Neoplasia 1 (2012), 15-21.
54. A. Mazzocca, F. Dituri, L. Lupo, M. Quaranta, S. Antonaci and G. Giannelli, Tumor-secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts. Hepatology 3 (2011), 920-930.
55. U.E. Martinez-Outschoorn, S. Pavlides, A. Howell, R.G. Pestell, H.B. Tanowitz, F. Sotgia and M.P. Lisanti, Stromalepithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment. Int J Biochem Cell Biol 7 (2011), 1045-1051.
56. D.R. McCready, W.S. Yong, A.K. Ng, N. Miller, S. Done and B. Youngson, Influence of the new AJCC breast cancer staging system on sentinel lymph node positivity and falsenegative rates. J Natl Cancer Inst 11 (2004), 873-875.
57. M. Moes, A. Le Béchec, I. Crespo, C. Laurini, A. Halavatyi, G. Vetter, A. Del Sol and E. Friederich, A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition. PLoS One 4 (2012), e35440.
58. A.M. Moorman, R. Vink, H.J. Heijmans, J. van der Palen and E.A. Kouwenhoven, The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol 4 (2012), 307-313.
59. M. Morrow, J. Waters and E. Morris, MRI for breast cancer screening, diagnosis, and treatment. Lancet 9805 (2011), 1804-1811.
60. M.M. Mueller and N.E. Fusenig, Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 11 (2004), 839-849.
61. M.S. Nicoloso, R. Spizzo, M. Shimizu, S. Rossi and G.A. Calin, MicroRNAs-the micro steering wheel of tumour metastases. Nat Rev Cancer 4 (2009), 293-302.
62. S. Nilsson, C. Möller, K. Jirström, A. Lee, S. Busch, R. Lamb and G. Landberg, Downregulation of miR-92a is associated with aggressive breast cancer features and increased tumour macrophage infiltration. PLoS One 4 (2012), e36051.
63. J. Niu, Y. Shi, G. Tan, C.H. Yang, M. Fan, L.M. Pfeffer and Z.H. Wu, DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion, J Biol Chem, 26 (2012), 21783-21795.
64. S.R. Pfeffer, Two Rabs for exosome release. Nat Cell Biol 1 (2010), 3-4.
65. D.G. Phinney and D.J. Prockop, Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 11 (2007), 2896-2902.
66. J. Radojicic, A. Zaravinos, T. Vrekoussis, M. Kafousi, D.A. Spandidos and E.N. Stathopoulos, MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer. Cell Cycle 3 (2011), 507-517.
67. L. Rask, E. Balslev, S. Jørgensen, J. Eriksen, H. Flyger, S. Møller, E. Høgdall, T. Litman and B.S. Nielsen, High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer. APMIS 10 (2011), 663-673.
68. S. Ramachandran and V. Palanisamy, Horizontal transfer of RNAs: exosomes as mediators of intercellular communication. Wiley Interdiscip Rev RNA 2 (2012), 286-293.
69. V. Raviraj, H. Zhang, H.Y. Chien, L. Cole, E.W. Thompson and L. Soon, Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas. Clin Exp Metastasis 3 (2012), 273-292.
70. E. Resetkova, J.S. Reis-Filho, R.K. Jain, R. Mehta, M.A. Thorat, H. Nakshatri and S. Badve, Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat 1 (2010), 97-108.
71. L.V. Rhodes, J.W. Antoon, S.E. Muir, S. Elliott, B.S. Beckman and M.E. Burow, Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk. Mol Cancer 9 (2010), 295.
72. J. Sandoval and M. Estelle, Cancer epigenomics: beyond genomics. Curr Opin Genet Dev 1 (2012), 50-55.
73. B.R. Schulman, A. Esquela-Kerscher and F.J. Slack, Reciprocal expression of lin-41 and the microRNAs let-7 and mir-125 during mouse embryogenesis. Dev Dyn 4 (2005), 1046-1054.
74. L.F. Sempere, M. Christensen, A. Silahtaroglu, M. Bak, C.V. Heath, G. Schwartz, W. Wells, S. Kauppinen and C.N. Cole, Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 24 (2007), 11612-11620.
75. C. Sevignani, G.A. Calin, L.D. Siracusa and C.M. Croce, Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 3 (2006), 189-202.
76. F. Sipos and O. Galamb, Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. World J Gastroenterol 7 (2012), 601-608.
77. A.E. Sirica, D.J. Campbell and C.I. Dumur, Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol 3 (2011), 276-284.
78. B. Song, C. Wang, J. Liu, X. Wang, L. Lv, L. Wei, L Xie, Y. Zheng and X. Song, MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res 1 (2010), 29.
79. F. Sotgia, F. Del Galdo, M.C. Casimiro, G. Bonuccelli, I. Mercier, D. Whitaker-Menezes, K.M. Daumer, J. Zhou, C. Wang, S. Katiyar, H. Xu, E. Bosco, A.A. Quong, B. Aronow, A.K. Witkiewicz, C. Minetti, P.G. Frank, S.A. Jimenez, E.S. Knudsen, R.G. Pestell and M.P. Lisanti, Caveolin-1-/- null mammary stromal fibroblasts share characteristics with human breast cancer-associated fibroblasts. Am J Pathol 3 (2009), 746-761.
80. J. Stingl, P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant and D. Choi, Purification and unique properties of mammary epithelial stem cells. Nature 7079 (2006), 993-997.
81. M. Terao, M. Fratelli, M. Kurosaki, A. Zanetti, V. Guarnaccia, G. Paroni, A. Tsykin, M. Lupi, M. Gianni, G.J. Goodall and E. Garattini, Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. J Biol Chem 5 (2011), 4027-4042.
82. V. Tjomsland, L. Niklasson, P. Sandström, K. Borch, H. Druid, C. Bratthäll, D. Messmer, M. Larsson and A. Spångeus, The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma. Clin Dev Immunol 2011 (2011), 212810.
83. A.J. Trimboli, C.Z. Cantemir-Stone, F. Li, J.A. Wallace, A. Merchant, N. Creasap, J.C. Thompson, E. Caserta, H. Wang, J.L. Chong, S. Naidu, G. Wei, S.M. Sharma, J.A. Stephens, S.A. Fernandez, M.N. Gurcan, M.B. Weinstein, S.H. Barsky, L. Yee, T.J. Rosol, P.C. Stromberg, M.L. Robinson, F. Pepin, M. Hallett, M. Park, M.C. Ostrowski and G. Leone, Pten in stromal fibroblasts suppresses mammary epithelial tumours. Nature 7267 (2009), 1084-1091.
84. Y.C. Tsai, Y. Lu, P.W. Nichols, G. Zlotnikov, P.A. Jones and H.S. Smith, Contiguous patches of normalhuman mammary epithelium derived from a single stem cell: Implications for breast carcinogenesis. Cancer Research 56 (1996), 402-404.
85. A.M. Tokes, A.M. Szasz, A. Farkas, M. Dank, L. Harsanyi, B.A. Molnar, I.A. Molnar, Z. Laszlo, Z. Rusz and J. Kulka, Stromal matrix protein expression following preoperative systemic therapy in breast cancer. Clin Cancer Res 2 (2009), 731-739.
86. S. Valastyan, F. Reinhardt, N. Benaich, D. Calogrias, A.M. Szász, Z.C. Wang, J.E. Brock, A.L. Richardson and R.A. Weinber, A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 6 (2009), 1032-1046.
87. J.A. Wallace, F. Li, G. Leone and M.C. Ostrowsk, Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. Cancer Res 4 (2011), 1203-1207.
88. R. Wang, H.B. Wang, C.J. Hao, Y. Cui, X.C. Han, Y. Hu, F.F. Li, H.F. Xia and X. Ma, MiR-101 Is Involved in Human Breast Carcinogenesis by Targeting Stathmin1. PLoS One 10 (2012), e46173.
89. S.A. Williams, Y. Harata-Lee, I. Comerford, R.L. Anderson, M.J. Smyth and S.R. McColl, Multiple functions of CXCL12 in a syngeneic model of breast cancer. Mol Cancer 9 (2010), 250.
90. Z.S. Wu, C.Q. Wang, R. Xiang, X. Liu, S. Ye, X.Q. Yang, G.H. Zhang, X.C. Xu, T. Zhu and Q. Wu, Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer 12 (2012), 51.
91. C. Yates, Prostate tumor cell plasticity: a consequence of the microenvironment. Adv Exp Med Biol 720 (2011), 81-90.
92. L. Zhang, J. Huang, N. Yang, J. Greshock, M.S. Megraw, A. Giannakakis, S. Liang, T.L. Naylor, A. Barchetti, M.R. Ward, G. Yao, A. Medina, A. O'Brien-Jenkins, D. Katsaros, A. Hatzigeorgiou, P.A. Gimotty, B.L. Weber and G. Coukos, MicroRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 24 (2006), 9136-9141.
93. Z. Zhang, B. Zhang, W. Li, L. Fu, L. Fu, Z. Zhu and J.T. Dong, Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells. Genes Cancer 8 (2011), 782-791.
94. S. Zhu, H. Wu, F. Wu, D. Nie, S. Sheng and Y.Y. Mo, MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 3 (2008), 350-359.